Actively Recruiting
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation
Led by The University of Hong Kong · Updated on 2024-11-27
1000
Participants Needed
2
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.
CONDITIONS
Official Title
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older who received allogeneic hematopoietic stem cell transplantation (allo-HSCT).
You will not qualify if you...
- Unable to give informed consent in a prospective cohort.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Department of Medicine, Queen Mary Hospital
Hong Kong, Hong Kong
Actively Recruiting
2
Queen Mary Hospital, Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
Research Team
H
Harry HS Gill, MBBS, MD, FRCP, FRCPath
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here